1V-LSD Valerie 225mcg is a synthetic psychedelic compound belonging to the lysergamide family. It is a derivative of LSD (lysergic acid diethylamide) and shares similarities in chemical structure and effects. Structurally, it consists of a lysergic acid backbone with a propionyl group attached to the nitrogen atom at the 1-position. Each 1V-LSD Valerie blotter contains 225 micrograms (mcg) of the compound.
Researchers often report visual and auditory hallucinations, altered perception of time and space, and an enhanced sense of introspection when using this product. The effects typically occur within 30–60 minutes after ingestion and can last for 8-12 hours, with residual effects lasting up to 24 hours. It is important to note that this dosage is considered moderate to high and is intended for experienced researchers.
Safety and responsible use are crucial when working with this product. It should only be used by informed and experienced researchers in a controlled and safe environment. Proper dosage guidelines and harm reduction strategies should be followed. Set and setting play a significant role in the overall experience.
Ordering Information on 1v-lsd
To inquire about pricing and availability of 1V-LSD Valerie 225mcg, please contact our customer support team or visit our website. We are dedicated to providing excellent customer service and ensuring a smooth ordering process. At Substitute Chemicals, we prioritize privacy and discretion, handling all orders with confidentiality and using discreet packaging for shipping. We offer worldwide shipping to accommodate researchers globally.
Unlock the potential of 1V-LSD Valerie 225mcg in your research endeavors. Join the community of researchers at the forefront of scientific advancements by ordering 1V-LSD Valerie 225mcg today. Contact our customer support team or visit our website to inquire about pricing and availability.
We look forward to serving you and contributing to your research endeavors with our high-quality 1V-LSD Valerie 225mcg.
Reviews
There are no reviews yet.